Jonas Brambeck

Senior Investment Director

Joined: 1998

Involved in: Gesynta, Oncopeptides, MinervaX

Interests: Diagnostics, MedTech, Therapeutics, Life Science, Pharma

Jonas Brambeck

Jonas focuses on Life Science and since joining Industrifonden in 1998 he has lead a number of investments in pharma and diagnostics.

He has an extensive experience in financing, divestments and public offerings in Life Science companies as well as a significant board experience.

Jonas holds a PhD in Organic chemistry from the Royal Institute of Technology, Stockholm.